Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort study
M Grymonprez, M Petrovic, TL De Backer… - … Journal-Quality of …, 2024 - academic.oup.com
Aims Data on non-vitamin K antagonist oral anticoagulants (NOACs) use in patients with
atrial fibrillation (AF) and frailty are scarce. Therefore, the impact of frailty on AF-related …
atrial fibrillation (AF) and frailty are scarce. Therefore, the impact of frailty on AF-related …
Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort study
M Grymonprez, M Petrovic… - … journal. Quality of …, 2024 - pubmed.ncbi.nlm.nih.gov
Aims Data on non-vitamin K antagonist oral anticoagulants (NOACs) use in patients with
atrial fibrillation (AF) and frailty are scarce. Therefore, the impact of frailty on AF-related …
atrial fibrillation (AF) and frailty are scarce. Therefore, the impact of frailty on AF-related …
[PDF][PDF] Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort …
M Grymonprez, M Petrovic, TL De Backer, S Steurbaut… - 2023 - backoffice.biblio.ugent.be
Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants
(NOACs) in patients with atria Page 1 European Heart Journal - Quality of Care and Clinical …
(NOACs) in patients with atria Page 1 European Heart Journal - Quality of Care and Clinical …
[PDF][PDF] Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort …
M Grymonprez, M Petrovic, TL De Backer, S Steurbaut… - 2023 - academia.edu
Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral
anticoagulants (NOACs) in patients with atria Page 1 European Heart Journal - Quality of …
anticoagulants (NOACs) in patients with atria Page 1 European Heart Journal - Quality of …
Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort study.
M Grymonprez, M Petrovic, TL De Backer… - … Heart journal. Quality …, 2024 - europepmc.org
Aims Data on non-vitamin K antagonist oral anticoagulants (NOACs) use in patients with
atrial fibrillation (AF) and frailty are scarce. Therefore, the impact of frailty on AF-related …
atrial fibrillation (AF) and frailty are scarce. Therefore, the impact of frailty on AF-related …
Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort study
M Grymonprez, M Petrovic, T De Backer… - … -QUALITY OF CARE …, 2024 - biblio.ugent.be
Data on non-vitamin K antagonist oral anticoagulants (NOACs) use in patients with atrial
fibrillation (AF) and frailty are scarce. Therefore, the impact of frailty on AF-related outcomes …
fibrillation (AF) and frailty are scarce. Therefore, the impact of frailty on AF-related outcomes …
Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort study
M Grymonprez, M Petrovic, TL De Backer… - … Journal-Quality of …, 2024 - academic.oup.com
Aims Data on non-vitamin K antagonist oral anticoagulants (NOACs) use in patients with
atrial fibrillation (AF) and frailty are scarce. Therefore, the impact of frailty on AF-related …
atrial fibrillation (AF) and frailty are scarce. Therefore, the impact of frailty on AF-related …
[HTML][HTML] Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort …
M Grymonprez, M Petrovic, TL De Backer… - … Heart Journal. Quality …, 2024 - ncbi.nlm.nih.gov
Aims Data on non-vitamin K antagonist oral anticoagulants (NOACs) use in patients with
atrial fibrillation (AF) and frailty are scarce. Therefore, the impact of frailty on AF-related …
atrial fibrillation (AF) and frailty are scarce. Therefore, the impact of frailty on AF-related …
Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort study
M Grymonprez, M Petrovic… - … journal. Quality of …, 2024 - researchportal.vub.be
AIMS: Data on non-vitamin K antagonist oral anticoagulants (NOACs) use in patients with
atrial fibrillation (AF) and frailty are scarce. Therefore, the impact of frailty on AF-related …
atrial fibrillation (AF) and frailty are scarce. Therefore, the impact of frailty on AF-related …
[PDF][PDF] Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a nationwide cohort …
M Grymonprez, M Petrovic, TL De Backer, S Steurbaut… - 2023 - researchgate.net
Impact of frailty on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants
(NOACs) in patients with atria Page 1 European Heart Journal - Quality of Care and Clinical …
(NOACs) in patients with atria Page 1 European Heart Journal - Quality of Care and Clinical …